AGAP2 and non-small cell lung carcinoma: Both exosomal TBILA (exo-TBILA) and exosomal AGAP2-AS1 (exo-AGAP2-AS1) expression are higher in the serum of NSCLC patients than in exosomes-depleted serum (EDS) from NSCLC patients or serum of healthy patients.